News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Dr. Louise Guolla elected Vice-Chair of the Young SIOP Network
Photo taken from SIOP/LinkedIn
Apr 12, 2024, 11:30

Dr. Louise Guolla elected Vice-Chair of the Young SIOP Network

International Society of Pediatric Oncology posted on LinkedIn:

“Congratulations to Dr. Louise Guolla (Canada) on being elected Vice-Chair of the Young SIOP Network (YSN) (2024-2026). ”

Read further
Source: International Society of Pediatric Oncology/LinkedIn

cancer International Society of Pediatric Oncology Louise Guolla OncoDaily Oncology SIOP Young SIOP Network YSN
Special Coverage
Science
Mar 21, 2025, 18:33
Yan Leyfman: Researchers have shed light on a critical aspect of CAR-T therapy - long-term complications
Blog
Mar 21, 2025, 18:26
Applications are open for the M2ICOS project - European School of Oncology
Blog
Mar 21, 2025, 18:19
Douglas Flora: American Cancer Society Cincinnati Golf Classic 2025
Blog
Mar 21, 2025, 18:12
Kim Stanbery: Celebrating our incredible oncology nurses
Blog
Mar 21, 2025, 18:06
Penilla Gunther: Fun to meet different companies in Life Science
Blog
Mar 21, 2025, 18:00
Jordan Rathkopf: Can hospitals use art to challenge, not just comfort?
Blog
Mar 21, 2025, 17:49
Mieke Van Hemelrijck: Our TOUR team will be attending EAU25 in Madrid
Blog
Mar 21, 2025, 17:43
Thomas Hofmarcher: Launch of the 2025 IHE Comparator Report on Cancer in Europe
Science
Mar 21, 2025, 17:36
Pierre Foidart: Patients-related outcomes in OlympiA
Blog
Mar 21, 2025, 17:25
Mila’s story: Overcoming silence and raising awareness for CRC in young adults - Digestive Cancers Europe
Career
Mar 21, 2025, 17:15
Noha Rashad: I have earned the "Certificate of Professional Development in Upper GI Cancers" from ESMO
Blog
Mar 21, 2025, 17:04
Alicia Zhou: Fighting for the future of cancer science amid NIH disruptions